TAKEDA PHARMACEUTICAL COMPANY LIMITED

(4502)
  Rapport
Temps Différé Japan Exchange  -  04:30 15/08/2022
3812.00 JPY   +0.37%
01/08TAKEDA PHARMACEUTICAL COMPANY LIMITED : Jefferies & Co. passe à neutre sur le dossier
ZM
29/07Le bénéfice attribuable de Takeda Pharmaceutical au premier trimestre fiscal chute de 24 %.
MT
28/07Takeda affiche un bénéfice de base et des revenus plus élevés au premier trimestre fiscal
MT
SynthèseCotationsGraphiquesActualitésNotationsAgendaSociétéFinancesConsensusRévisionsDérivésFonds 
SynthèseToute l'actualitéReco analystesAutres languesCommuniquésPublications officiellesActualités du secteurAnalyses Zonebourse
Actualités dans d'autres langues sur TAKEDA PHARMACEUTICAL COMPANY LIMITED
04/08TAKEDA PHARMACEUTICAL : Quarterly Securities Report for the 1st Quarter
03/08Poseida Therapeutics Shares Soar After Roche Collaboration
31/07Takeda liefert im ersten Quartal GJ2022 starke Ergebnisse; auf Kurs in Richtung der Jah..
31/07Takeda logra resultados sólidos en el primer trimestre del año fiscal 2022 y se encuent..
29/07Takeda Pharmaceutical's Fiscal Q1 Attributable Profit Slides 24%
28/07TRANSCRIPT : Takeda Pharmaceutical Company Limited, Q1 2023 Earnings Call, Jul 28, 2022
28/07Takeda Posts Higher Fiscal Q1 Core Profit, Revenue
28/07Takeda Pharmaceutical's First-Quarter Net Profit Fell 24% From High Base
28/07Takeda sees quarterly profit drop 39% after last year's one-time gains
28/07Takeda Delivers Strong First Quarter FY2022 Results; On Track Towards Full-Year Managem..
28/07Takeda Pharmaceutical Company Limited Reports Earnings Results for the First Quarter En..
28/07Takeda Pharmaceutical Company Limited Provides Consolidated Earnings Guidance for Year ..
28/07Takeda Pharmaceutical Company Limited Announces Dividend Guidance for Second Quarter an..
22/07Takeda anuncia resultados positivos del ensayo clínico fundamental de fase 3 que evalúa..
21/07Takeda gibt positive Topline-Ergebnisse der klinischen Phase-3-Studie zur Prüfung von H..
21/07Takeda Pharmaceutical Says Phase 3 Trial of Autoimmune Disorder Treatment Met Primary E..
21/07Takeda Announces Positive Topline Results from Pivotal Phase 3 Clinical Trial Evaluatin..
21/07Takeda Announces Positive Topline Results from Pivotal Phase 3 Clinical Trial Evaluatin..
21/07Dolphin Unit Closes $8 Million Purchase of High Reserve F&B in Cash-Stock Deal; Dolphin..
20/07F-star Therapeutics to Grant Takeda License for Immuno-oncology Bispecific Antibody
18/07Takeda to Hold First Quarter Earnings Call on July 28
15/07TAKEDA PHARMACEUTICAL : to Hold First Quarter Earnings Call on July 28
12/07Takeda gibt die Einreichung seines Corporate-Governance-Berichts an die Tokioter Börse ..
12/07Takeda Anuncia la Presentación de su Informe de Gobierno Corporativo a la Bolsa de Valo..
11/07Takeda Places Focus on Personalized Care and Innovation for Bleeding Disorders at ISTH ..
11/07Takeda Announces the Submission of its Corporate Governance Report to the Tokyo Stock E..
11/07TAKEDA PHARMACEUTICAL : I.Basic Views on Corporate Governance and Basic Information on Cap..
05/07En medio de la suspensión de la FDA, Denali pone en marcha un estudio sobre el Alzheime..
01/07Takeda's Takhzyro Shows 94.8% Reduction in Hereditary Angioedema Attacks in Phase 3 Tri..
01/07TAKEDA PHARMACEUTICAL : Phase 3 SPRING study data presented at EAACI
01/07Takeda's TAKHZYRO® (lanadelumab) Demonstrated Positive Results in the Prevention of HAE..
01/07Takeda Pharmaceutical Company Limited Demonstrates Positive Results in the Prevention o..
29/06TAKEDA PHARMACEUTICAL : Executive compensation overview
29/06TAKEDA PHARMACEUTICAL : Announces the Publication of its Annual Report on Form 20-F for FY..
29/06TAKEDA PHARMACEUTICAL : ARTICLES OF INCORPORATION OF TAKEDA PHARMACEUTICAL COMPANY LIMITED..
29/06TAKEDA PHARMACEUTICAL : Announces New Assignments of Directors - Form 6-K
29/06Takeda Pharmaceutical Company Limited Announces New Assignments of Directors
29/06Takeda Pharmaceutical Company Limited Announces Board Appointments
29/06Takeda Pharmaceutical Company Limited Approves Dividend for the Year Ended March 31, 20..
29/06TAKEDA PHARMACEUTICAL : Announces New Assignments of Directors
28/06Takeda - Results from Phase 2 Study of Fazirsiran in Patients with Alpha-1 Antitrypsin ..
27/06The New England Journal of Medicine publica los resultados del estudio de fase 2 de faz..
27/06Results from Phase 2 Study of Fazirsiran in Patients with Alpha-1 Antitrypsin Deficienc..
27/06Takeda and Arrowhead Announce Results from Phase 2 Study of Fazirsiran in Patients with..
24/06Takeda Pharmaceutical to Absorb Businesses From Unit Nihon Pharmaceutical
22/06Takeda Announces Creation of One Cambridge Campus in Kendall Square to Drive Innovation..
22/06Takeda Signs 15-Year Lease with BioMed Realty
17/06MARKETSCREENER'S WORLD PRESS REVIEW : June 17, 2022
17/06Takeda, Nintendo among Japanese firms quietly celebrating weak yen
10/06Takeda's Dengue Vaccine Candidate Provides Continued Protection Against Dengue Fever Th..
10/06TAKEDA PHARMACEUTICAL : Notice Concerning Disposal of Treasury Shares under the Long-Term ..
09/06La vacuna candidata de Takeda contra el dengue ofrece protección contra esta enfermedad..
09/06Dengue-Impfstoffkandidat von Takeda bietet einer zulassungsrelevanten klinischen Studie..
09/06Takeda Pharmaceutical Says Dengue Vaccine Candidate 84% Effective Against Hospitalizati..
09/06Takeda's Dengue Vaccine Candidate Provides Continued Protection Against Dengue Fever Th..
07/06Takeda Canada applauds Quebec's new Rare Disease Policy
02/06Asian ADRs Move Higher in Thursday Trading
02/06Takeda Pharmaceutical Company Limited - Notice Concerning Withdrawal of Shelf Registrat..
01/06Takeda Pharmaceutical to Pass On Marketing Authorization of COVID-19 Vaccine Spikevax i..
01/06Japan Index Posts Moderate Gains as Border Restrictions Ease; Mercari Shares Surge 7%
31/05Takeda präsentiert neueste Forschungsergebnisse aus Onkologie-Portfolio und Pipeline au..
31/05Takeda und Moderna geben Pläne zur Übertragung der Marktzulassung für den COVID-19-Impf..
31/05Takeda presenta en ASCO y EHA las últimas investigaciones de su cartera de productos y ..
31/05Takeda y Moderna anuncian su intención de transferir a Moderna la autorización de comer..
31/05Takeda and Moderna Announce Plans to Transfer Marketing Authorization for SpikevaxTM CO..
31/05Takeda Presents Latest Research from Oncology Portfolio and Pipeline at ASCO & EHA
31/05TAKEDA PHARMACEUTICAL : Current Report by Foreign Issuer (Form 6-K)
31/05TAKEDA PHARMACEUTICAL : Current Report by Foreign Issuer (Form 6-K)
31/05Moderna to Receive Marketing Authorization Transfer for COVID-19 Vaccine in Japan From ..
31/05Takeda and Moderna Announce Plans to Transfer Marketing Authorization for Spikevax&trad..
31/05Takeda and Moderna Announce Plans to Transfer Marketing Authorization for Spikevax™..
31/05SANITÀ : il pharma rimane zavorrato (MF)
30/05Takeda y Seagen destacan los datos del estudio de ADCETRIS® en combinación, que muestra..
29/05Takeda und Seagen präsentieren Daten zu ADCETRIS®-Kombination, die statistisch signifik..
27/05TAKEDA PHARMACEUTICAL : and Seagen to Highlight ADCETRIS Combination Data
1  2  3  4  5  6  7  8  9  10Suiv.
Prochain événement sur TAKEDA PHARMACEUTICAL COMPANY LIMITED